768 related articles for article (PubMed ID: 28274252)
1. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
Shi H; Ye J; Teng J; Yin Y; Hu Q; Wu X; Liu H; Cheng X; Su Y; Liu M; Gu J; Lu T; Chen H; Zheng H; Sun Y; Yang C
Arthritis Res Ther; 2017 Mar; 19(1):52. PubMed ID: 28274252
[TBL] [Abstract][Full Text] [Related]
2. Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
Zhou Z; Xu A; Teng J; Wang F; Tan Y; Liu H; Cheng X; Su Y; Shi H; Hu Q; Chi H; Li J; Hou J; Sun Y; Yang C; Ye J
J Immunol Res; 2020; 2020():2180708. PubMed ID: 33224991
[TBL] [Abstract][Full Text] [Related]
3. Anti-class a scavenger receptor autoantibodies from systemic lupus erythematosus patients impair phagocytic clearance of apoptotic cells by macrophages in vitro.
Chen XW; Shen Y; Sun CY; Wu FX; Chen Y; Yang CD
Arthritis Res Ther; 2011 Jan; 13(1):R9. PubMed ID: 21281474
[TBL] [Abstract][Full Text] [Related]
4. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
5. Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.
Sun J; Li X; Zhou H; Liu X; Jia J; Xie Q; Peng S; Sun X; Wang Q; Yi L
J Immunol Res; 2019; 2019():7430780. PubMed ID: 31049359
[TBL] [Abstract][Full Text] [Related]
6. Decreased serum thrombospondin-1 and elevation of its autoantibody are associated with multiple exacerbated clinical manifestations in systemic lupus erythematosus.
Meng Y; Zhang M; Zhao X; Cheng Y; Jia R; Wang Y; Sun X
Clin Rheumatol; 2018 Oct; 37(10):2707-2714. PubMed ID: 29998369
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against carbamylated vimentin exist in systemic lupus erythematosus and correlate with disease activity.
Li Y; Jia R; Liu Y; Tang S; Ma X; Shi L; Zhao J; Hu F; Li Z
Lupus; 2020 Mar; 29(3):239-247. PubMed ID: 31930936
[TBL] [Abstract][Full Text] [Related]
8. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
[TBL] [Abstract][Full Text] [Related]
9. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus.
Colasanti T; Maselli A; Conti F; Sanchez M; Alessandri C; Barbati C; Vacirca D; Tinari A; Chiarotti F; Giovannetti A; Franconi F; Valesini G; Malorni W; Pierdominici M; Ortona E
Arthritis Rheum; 2012 Mar; 64(3):778-87. PubMed ID: 21968947
[TBL] [Abstract][Full Text] [Related]
11. Anti-tubulin-α-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations.
Zhao X; Cheng Y; Gan Y; Jia R; Zhu L; Sun X
Clin Rheumatol; 2018 May; 37(5):1229-1237. PubMed ID: 29427009
[TBL] [Abstract][Full Text] [Related]
12. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
[TBL] [Abstract][Full Text] [Related]
13. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
[TBL] [Abstract][Full Text] [Related]
15. [Increased serum C-C chemokine ligand 19 levels correlated with B cell abnormalities in systemic lupus erythematosus].
Liu HJ; Shi LJ; Hu FL; Yao HH; Li ZG; Jia Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):829-834. PubMed ID: 29045964
[TBL] [Abstract][Full Text] [Related]
16. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
Hasan SI; Mohd Ashari NS; Mohd Daud K; Che Husin CM
Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
[TBL] [Abstract][Full Text] [Related]
17. Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus.
Lin J; Yue LH; Chen WQ
Scand J Immunol; 2014 Feb; 79(2):131-6. PubMed ID: 24313261
[TBL] [Abstract][Full Text] [Related]
18. PD-1+CXCR5-CD4+T cells are correlated with the severity of systemic lupus erythematosus.
Lin J; Yu Y; Ma J; Ren C; Chen W
Rheumatology (Oxford); 2019 Dec; 58(12):2188-2192. PubMed ID: 31180450
[TBL] [Abstract][Full Text] [Related]
19. Aberrant T cell subsets and cytokines expression profile in systemic lupus erythematosus.
Zhou H; Hu B; Huang N; Mo X; Li W; Zhang B; Wei B; Gao M; Wang Y; Liu X; Liao J
Clin Rheumatol; 2018 Sep; 37(9):2405-2413. PubMed ID: 29785672
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing anti-IFN-γ IgG was increased in patients with systemic lupus erythematosus and associated with susceptibility to infection.
Chen L; Chi H; Teng J; Meng J; Zhang H; Su Y; Liu H; Ye J; Shi H; Hu Q; Zhou Z; Yang C; Sun Y; Cheng X
Clin Rheumatol; 2024 Jan; 43(1):189-198. PubMed ID: 37857784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
